Catalyst Wire Dossier Catalyst Wire Dossier

Guselekumab

guselekumab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Guselekumab, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy

See pricing